SCHEMBL3313660

SCHEMBL3313660

COc1ccc(NC(=O)c2ccc(Cl)nc2)cc1OC.COc1ccc(NC(=O)c2cnccc2Cl)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 1/20 0.55
KCNQ2 O43526 1/20 0.55
SMN1; SMN2 Q16637 5/20 0.52
ALDH1A1 P00352 4/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
LMNA P02545 2/20 0.52
KDM4E B2RXH2 2/20 0.52
MAPT P10636 2/20 0.52
MAPK1 P28482 2/20 0.52
HTT P42858 2/20 0.52
MITF O75030 1/20 0.52
PKM P14618 1/20 0.52
GRM4 Q14833 2/20 0.51
RAB9A P51151 4/20 0.50
NPC1 O15118 2/20 0.50
TP53 P04637 1/20 0.50
ROCK2 O75116 1/20 0.50
ROCK1 Q13464 1/20 0.50
GAA P10253 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2304880 0.88 KCNQ3 (0.68) KCNQ3KCNQ2SMN1; SMN2ALDH1A1MEN1
SCHEMBL3309149 0.86 LMNA (0.58) KCNQ3KCNQ2SMN1; SMN2ALDH1A1MEN1
SCHEMBL3312207 0.85 KCNQ3 (0.63) KCNQ3KCNQ2SMN1; SMN2ALDH1A1MEN1
SCHEMBL3313663 0.84 LMNA (0.58) KCNQ3KCNQ2SMN1; SMN2ALDH1A1MEN1
SCHEMBL3309585 0.82 ROCK2 (0.53) KCNQ3KCNQ2SMN1; SMN2ALDH1A1MEN1
SCHEMBL12707696 0.79 P4HTM (0.67) SMN1; SMN2ALDH1A1MEN1KMT2ALMNA
SCHEMBL3312208 0.78 MEN1 (0.51) KCNQ3KCNQ2SMN1; SMN2MEN1KMT2A
SCHEMBL3309577 0.76 MEN1 (0.45) KCNQ3KCNQ2SMN1; SMN2ALDH1A1MEN1
SCHEMBL6606130 0.76 MCHR1 (0.62) KCNQ3KCNQ2SMN1; SMN2ALDH1A1MEN1
SCHEMBL3934629 0.76 LMNA (0.77) ALDH1A1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100113782-A1 Diacylglycerol Acyltransferase Inhibitors MADRIGAL PHARMACEUTICALS, INC. 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113782-A1 Diacylglycerol Acyltransferase Inhibitors DGAT2, DGAT1, MOGAT2 KCNQ3 410/4885KCNQ2 300/4885SMN1; SMN2 4749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.